Vanta Holdings attends 2026 All-In Summit in Los Angeles

• Vanta attended the 2026 All-In Summit in Los Angeles on Sept. 13-15.
• Meetings targeted founders, investors, executives across healthcare, biotechnology, technology aligned with its growth strategy.
• Engagements included U.S. peptide therapeutics contacts tied to a planned U.S. peptide therapy platform.
• Platform concept combines telehealth intake, physician workflows, FDA-registered compounding pharmacy fulfillment, compliant payments, subscription commercialization.
• Summit drew more than 2,500 attendees at the Shrine Auditorium and Expo Hall.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vanta Holdings Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202609171615ACCESSWRNAPR_____1223227) on September 17, 2026, and is solely responsible for the information contained therein.